Moreover, our secondary objective was to assess the relationships between these potential changes in tPA plasma levels and biological cardiovascular markers, cognition, brain structure, glucose metabolism and amyloid load, as relevant markers of aging and AD. The gene discussed is PLAT; the disease is Alzheimer disease.